Search alternatives:
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
Showing 441 - 460 results of 11,475 for search '(( 50 ms decrease ) OR ( 100 ((((nn decrease) OR (greater decrease))) OR (a decrease)) ))', query time: 0.56s Refine Results
  1. 441
    Analysis of >100,000 Cardiovascular Surgeries Performed at the Heart Institute and a New Era of Outcomes

    Analysis of >100,000 Cardiovascular Surgeries Performed at the Heart Institute and a New Era of Outcomes by Omar A.V. Mejia (8464695)

    Published 2020
    Save to List
    Saved in:
  2. 442
    Analysis of >100,000 Cardiovascular Surgeries Performed at the Heart Institute and a New Era of Outcomes

    Analysis of >100,000 Cardiovascular Surgeries Performed at the Heart Institute and a New Era of Outcomes by Omar A.V. Mejia (8464695)

    Published 2021
    Save to List
    Saved in:
  3. 443
    Table_3_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.xlsx

    Table_3_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.xlsx by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  4. 444
    Image_5_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif

    Image_5_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  5. 445
    Table_1_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.xlsx

    Table_1_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.xlsx by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  6. 446
    Table_2_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.xlsx

    Table_2_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.xlsx by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  7. 447
    Image_6_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif

    Image_6_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  8. 448
    Image_3_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif

    Image_3_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  9. 449
    Image_2_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif

    Image_2_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  10. 450
    Image_4_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif

    Image_4_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  11. 451
    Image_1_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif

    Image_1_Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.tif by Sze Wing Wong (1617550)

    Published 2022
    “…In support of this, we found decreased MDSC numbers, and increased numbers of CD4<sup>+</sup> T cells and natural killer T (NK-T) cells in lungs from cancer-bearing mice treated with S100A8. …”
    Save to List
    Saved in:
  12. 452
    Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC–MS/MS-Based Glycoproteomic Approach

    Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC–MS/MS-Based Glycoproteomic Approach by Jingfu Zhao (3113421)

    Published 2020
    “…Here, we applied an LC–MS/MS-based glycoproteomics approach to characterize Fc glycans of an NISTmAb reference material (RM) 8671 (sample B) and a β-1,4-galactosidase-treated NISTmAb (sample A). …”
    Save to List
    Saved in:
  13. 453
    A map indicating study areas and locations of samples.

    A map indicating study areas and locations of samples. by Matti Viluksela (321291)

    Published 2024
    Save to List
    Saved in:
  14. 454
    Trends in the age-standardized rate of YLDs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in the age-standardized rate of YLDs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  15. 455
    Trends in age-standardized rate of DALYs per 100,000 with caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in age-standardized rate of DALYs per 100,000 with caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  16. 456
    Trends in the age-standardized rate of YLLs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in the age-standardized rate of YLLs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  17. 457
    Trends in age-standardized rate of deaths per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in age-standardized rate of deaths per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  18. 458
    Crude incidence rates (95% CI) per 1000 patient years for components of MACE and all-cause death for the entire cohort and by level of MPO elevation at first measure.

    Crude incidence rates (95% CI) per 1000 patient years for components of MACE and all-cause death for the entire cohort and by level of MPO elevation at first measure. by Marc S. Penn (16624541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 459
    Causes of death as recorded in medical chart reported as percent of total deaths.

    Causes of death as recorded in medical chart reported as percent of total deaths. by Marc S. Penn (16624541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 460
    Characteristics of baseline MPO cohort and “change in MPO cohort” (patients with multiple MPO measures).

    Characteristics of baseline MPO cohort and “change in MPO cohort” (patients with multiple MPO measures). by Marc S. Penn (16624541)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: